Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for RECORDATI RARE DISEASES INC. · Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.

 Filing Registration
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Nov 14, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey

Official filing document

 Lobbyists on this filing 4
  • BOBBY MCMILLIN New on this filing
    Previously held: General Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007)
  • PETER ERIC DUYSHART New on this filing
    Previously held: Program Support Student Trainee, Secretarial Internship Program, U.S. DOT (2020); Intern, Rep. Karen Bass (2015-2016); Extern, U.S. Attorneys Office, Central District of California (2015)
  • VICTORIA DAVILA New on this filing
    Previously held: Intern, Rep. Pramila Jayapal (2024)
  • EUGENIA PIERSON New on this filing
    Previously held: Clerk, House Energy and Commerce Committee (2001-05)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 3
Health Issues

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the U.S.

Medicare/Medicaid

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the U.S.

Trade (domestic/foreign)

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the U.S.

 Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

  • RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
    Italy · Milan · owns 100% of the client · contributed $0.00

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem